Pagina inicial
Continue Watching
Últimos vídeos
Últimos vídeos
Brightcove Home Latest Listing
Oncology
Oncology
Brightcove Cards Listing
Hematology
Hematology
Brightcove Cards Listing
Popular em MedEnrich
Popular em MedEnrich
Popular in Sem nome
3m 36s
Tumor Infiltrating Lymphocytes as Predictive Biomarker in Breast Cancer
Immune cells known as tumor-infiltrating lymphocytes (TILs) are thought to be a promising, affordable biomarker with prognostic and predictive potential.
tumor-infiltrating lymphocytes (tils)
promising biomarker
1
Tumor Infiltrating Lymphocytes as Predictive...
3m 36s
Tumor Infiltrating Lymphocytes as Predictive Biomarker in Breast Cancer
Immune cells known as tumor-infiltrating lymphocytes (TILs) are thought to be a promising, affordable biomarker with prognostic and predictive potential.
tumor-infiltrating lymphocytes (tils)
promising biomarker
1
Tumor Infiltrating Lymphocytes as Predictive...
29m 30s
SABCS Update 2022
Summary of Key Abstracts from SABCS 2022
recurrence score
tailor-x
destiny breast 03
adjuvant cdk4/6 inhibitor
antibody drug conjugates
1
SABCS Update 2022
29m 30s
SABCS Update 2022
Summary of Key Abstracts from SABCS 2022
recurrence score
tailor-x
destiny breast 03
adjuvant cdk4/6 inhibitor
antibody drug conjugates
1
SABCS Update 2022
8m 55s
Understanding HER-2 Low Breast Cancer Entity & Treatment Strategy
Tumors with a HER-2 immunohistochemistry (IHC) score of 1 + or 2 + and a negative molecular reflex test have been classified as HER2-low Breast Cancers.
trastuzumab-deruxtecan (t-dxd)
her2 low breast cancers
1
Understanding HER-2 Low Breast Cancer Entity &...
8m 55s
Understanding HER-2 Low Breast Cancer Entity & Treatment Strategy
Tumors with a HER-2 immunohistochemistry (IHC) score of 1 + or 2 + and a negative molecular reflex test have been classified as HER2-low Breast Cancers.
trastuzumab-deruxtecan (t-dxd)
her2 low breast cancers
1
Understanding HER-2 Low Breast Cancer Entity &...
Câncer de próstata11m 38s
Treatment Intensification in Metastatic Castration Sensitive Prostate Cancer
PEACE-1 clinical trial demonstrated that combining ADT and docetaxel with abiraterone acetate plus prednisone (AAP) improves both overall survival (OS) and radiographic progression-free-survival (rPFS) in men with de novo mCSPC.
treatment intensification
mhspc
triplet therapy
peace-1 clinical trial
1
Treatment Intensification in Metastatic Castration...
Mieloma múltiplo3m 0s
Programa de Preceptoria em Mieloma Múltiplo - Principais mensagens do diretor do programa.
Assista a uma vídeo aula que aborda a as principais mensagens do programa de preceptoria em mileoma múltiplo, realizado em Navarra - Espanha.
mm
mieloma múltiplo
tratamento
takeaways
principais mensagens
preceptoria
1
Programa de Preceptoria em Mieloma Múltiplo -...
8m 46s
Expert Perspective - How I Treat Metastatic Her2 Positive Breast Cancer
Anti-HER2 directed therapy remains the cornerstone of care for individuals with HER2-positive metastatic breast cancer (MBC).
anti-her2 directed therapy
her2-positive metastatic breast cancer
expert perspective
algorithm for management of her2 positive mbc
1
Expert Perspective - How I Treat Metastatic Her2...
8m 46s
Expert Perspective - How I Treat Metastatic Her2 Positive Breast Cancer
Anti-HER2 directed therapy remains the cornerstone of care for individuals with HER2-positive metastatic breast cancer (MBC).
anti-her2 directed therapy
her2-positive metastatic breast cancer
expert perspective
algorithm for management of her2 positive mbc
1